{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Syn X Pharma", "item": "https://www.patentleaderboard.com/company/syn-x-pharma"}, {"@type": "ListItem", "position": 3, "name": "John Marshall", "item": "https://www.patentleaderboard.com/inventor/fl:jo_ln:marshall-36"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Syn X Pharma › John Marshall
JM

John Marshall — 66 Patents

SPSyn X Pharma: 26 patents #2 of 11Top 20%
GEGenzyme: 17 patents #22 of 891Top 3%
NANanogen: 9 patents #9 of 86Top 15%
BUBrown University: 4 patents #33 of 478Top 7%
TIThe University Of Iowa: 1 patents #4 of 47Top 9%
UNUnknown: 1 patents #29,356 of 83,584Top 40%
Chicago, IL: #78 of 13,327 inventorsTop 1%
Illinois: #462 of 84,256 inventorsTop 1%
Overall (All Time): #32,599 of 4,157,543Top 1%
66 Patents All Time
John Marshall has been granted 66 US patents while listed as an inventor at Syn X Pharma. The first was granted in 1997 and the most recent in March 2025. John Marshall ranks #32,599 of 4,157,543 US inventors in our database (top 0.78%). Patent records list John Marshall in Chicago, IL, US.

Patents per Year

Patents granted per year, 1997 to 2025Bar chart with a peak of 16 patents in 2006.peak 161997: 1 patents19971998: 4 patents1999: 6 patents19992000: 1 patents2001: 1 patents20012002: 1 patents2003: 9 patents20032004: 4 patents2005: 3 patents20052006: 16 patents2007: 5 patents20072008: 3 patents2014: 1 patents20142016: 1 patents2018: 3 patents20182021: 1 patents2022: 1 patents20222023: 1 patents2024: 2 patents20242025: 2 patents2025

Issued Patents All Time

Showing 1–25 of 66 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12257292 Enhanced delivery of antioxidants for treatment of central nervous system disorders involving oxidative stress Ryan Kole, Meriel Owen 2025-03-25
12240920 Cyclic peptidomimetic for the treatment of neurological disorders — 2025-03-04
12060349 Glucosylceramide synthase inhibitors Elyse Bourque, Mario CABRERA-SALAZAR, Cassandra Celatka, Seng H. Cheng, Bradford H. Hirth +12 more 2024-08-13
11879020 Cyclic peptidomimetic for the treatment of neurological disorders — 2024-01-23
11612642 Enhanced delivery of antioxidants for treatment of central nervous system disorders involving oxidative stress Ryan Kole, Meriel Owen 2023-03-28
11498018 Extraction and purification of cannabinoid compounds Lesley G. Campbell 2022-11-15
11008316 Glucosylceramide synthase inhibitors Elyse Bourque, Mario CABRERA-SALAZAR, Cassandra Celatka, Seng H. Cheng, Bradford H. Hirth +12 more 2021-05-18
10046024 Cyclic-GluR6 analogs, methods of treatment and use Mark Spaller, Dennis J. Goebel 2018-08-14
10040822 Neuroprotective composition and method of use Dennis J. Goebel 2018-08-07
9964538 Methods and compositions for enzyme linked immuno and hybridization mass spectrometric assay Angelica Kirsten Florentinus 2018-05-08
9403876 Cyclic-GluR6 analogs, methods of treatment and use Mark Spaller, Dennis J. Goebel 2016-08-02
8673857 Long term potentiation with cyclic-GluR6 analogs Andrew Peter Mallon 2014-03-18
7329501 Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance George Jackowski 2008-02-12 $599,000
7314762 Apolipoprotein biopolymer markers indicative of insulin resistance George Jackowski 2008-01-01
7314717 Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons George Jackowski, Brad Thatcher, Jason Yantha, Tammy Vrees 2008-01-01
7294688 Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons George Jackowski, Brad Thatcher, Jason Yantha, Tammy Vrees 2007-11-13 $830,000
7229638 Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons George Jackowski, Brad Thatcher, Jason Yantha, Tammy Vrees 2007-06-12
7179606 IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease George Jackowski 2007-02-20
7179605 Fibronectin precursor biopolymer markers indicative of alzheimer's disease George Jackowski 2007-02-20 $645,000
7179610 Complement C3 precursor biopolymer markers indicative of insulin resistance George Jackowski 2007-02-20 $645,000
7135297 Protein biopolymer markers indicative of insulin resistance George Jackowski 2006-11-14 $818,000
7132244 Betaine/GABA transport protein biopolymer marker indicative of insulin resistance George Jackowski 2006-11-07
7125678 Protein biopolymer markers predictive of type II diabetes George Jackowski 2006-10-24 $1,757,000
7125726 Method and kit for diagnosing myocardial infarction George Jackowski, Brad Thatcher, Jason Yantha, Tammy Vrees 2006-10-24
7122327 Biopolymer markers indicative of type II diabetes George Jackowski 2006-10-17 $1,728,000

Frequent Collaborators

George Jackowski38 shared
Brad Thatcher22 shared
Jason Yantha22 shared
Tammy Vrees22 shared
Seng H. Cheng17 shared
Ronald K. Scheule13 shared

Nearby-Ranked Inventors

June-Woo Lee66
Christian Schneider66
John C. Oslund66
Pankaj J. Pasricha66
Roger Graham Hall66
Miao Yu66
David P. Smith66
Andreas Knorr66
Hitoshi Kawaguchi66